Ardian took a majority stake in Theradial alongside historical shareholder UI Investissement. Bpifrance and the management team remain minority shareholders. The transaction, valuing the company between EUR100M and EUR200M, aims to accelerate international expansion and support a buy-and-build strategy, particularly in data-driven healthcare solutions.

This transaction is part of the Healthcare & Pharma industry, which currently tracks an average EBITDA multiple of 13.4x since the beginning of 2026, 1.2% decrease compared to 2025. This data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.